Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis

9 Aug 2022

Abstract excerpt

The expression of angiopoietin (ANGPT) 1, ANGPT2, vascular endothelial growth factor (VEGF) A, VEGFB, VEGFC, VEGFD, and placental growth factor (PGF) is significantly higher in tumor tissues than in normal tissues in both unpaired and paired hepatocellular carcinoma (HCC) samples. ANGPT2, VEGFB, VEGFC, and PGF are primarily involved in regulating the activation of the epithelial-mesenchymal transition pathway;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Kruppel-like factors research
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36157115
DOI: 10.3748/wjg.v28.i30.4221

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysisPMID 36157115Read ↗

Comprehensive Analysis for Anti-Cancer Target-Indication Prioritization of Placental Growth Factor Inhibitor (PGF) by Use of Omics and Patient Survival DataSemantic proximity Read ↗

To construct and validate a risk score model of angiogenesis-related genes to predict the prognosis of hepatocellular carcinomaSemantic proximity Read ↗

Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinomaSemantic proximity Read ↗

Analysis of Immune-Related and Angiogenesis-Related Genes in Hepatocellular Carcinoma: Implications for Prognosis and Drug SensitivitySemantic proximity Read ↗

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular CarcinomaSemantic proximity Read ↗

Comprehensive analysis prediction prognosis and immune therapy value of angiogenesis-associated genes in kidney renal clear cell carcinomaSemantic proximity Read ↗

Development of a novel angiogenesis-associated gene model for prognosis prediction in colorectal cancer.Semantic proximity Read ↗

Prognostic Hypoxia-Angiogenesis-Related Gene Signature in Hepatocellular Carcinoma, in Which HILPDA Contributes to Tumor ProgressionSemantic proximity Read ↗

Differential expression of angiogenesis-related genes ‘VEGF’ and ‘angiopoietin-1’ in metastatic and EMAST-positive colorectal cancer patientsSemantic proximity Read ↗

Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Acts as Diagnostic Biomarker and Adverse Prognostic Factor of Hepatocellular Carcinoma (HCC): Evidence from Bioinformatic Analysis.Semantic proximity Read ↗

Integrative Identification of Angiogenesis-Related Genes for Predicting Immune Interaction and Prognosis in LUADSemantic proximity Read ↗

Identification of angiogenesis‐related genes signature for predicting survival and its regulatory network in glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.